Atezolizumab Plus Chemo Misses Mark in TNBC ...Middle East

The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with stages II-III triple-negative breast cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Atezolizumab Plus Chemo Misses Mark in TNBC )

Also on site :

• Why Steve Sarkisian and oddsmakers are exactly right about the new era of the SEC
• New federal Covid-19 vaccine policies are already keeping some people from getting shots
• Robert De Niro, 81, Makes Rare Public Appearance With Daughter Helen, 13